Signet Therapeutics
Pioneering the future of cancer treatment with breakthrough targeted therapies and innovative disease models
Pioneering the future of cancer treatment with breakthrough targeted therapies and innovative disease models
Signet Therapeutics is a biopharmaceutical startup founded in 2020, dedicated to pioneering the future of cancer treatment by developing breakthrough targeted therapies and innovative disease models. The company's slogan, "Pioneering the future of cancer treatment with breakthrough targeted therapies and innovative disease models," reflects its commitment to innovation in the biotechnology industry. In October 2021, Signet Therapeutics secured a significant milestone by receiving a $10.00M Seed Round investment from prominent investors including Sky9 Capital, 5Y Capital, Blue Ocean Capital, Taihill Venture, Tiantu Capital, and Yael Capital Management Limited. This investment underscores the confidence of key players in the industry in Signet Therapeutics' innovative approach to cancer treatment.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $10.00M | 6 |
|
29 Oct 2021 |
| Seed Round | $10.00M | 2 |
|
01 Jan 2020 |
No recent news or press coverage available for Signet Therapeutics.
-logo.jpg){kind=logo}
We care about your data, and we'd love to use cookies make your experience better.
